| Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists L Carmona, JJ Gómez‐Reino, V Rodríguez‐Valverde, D Montero, ... Arthritis & Rheumatism 52 (6), 1766-1772, 2005 | 814 | 2005 |
| Leptin in the interplay of inflammation, metabolism and immune system disorders V Abella, M Scotece, J Conde, J Pino, MA Gonzalez-Gay, ... Nature Reviews Rheumatology 13 (2), 100-109, 2017 | 494 | 2017 |
| Obesity, fat mass and immune system: role for leptin V Francisco, J Pino, V Campos-Cabaleiro, C Ruiz-Fernández, A Mera, ... Frontiers in physiology 9, 640, 2018 | 396 | 2018 |
| Systemic involvement in primary Sjögren’s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry) M Ramos-Casals, P Brito-Zeron, R Solans, MT Camps, A Casanovas, ... Rheumatology 53 (2), 321-331, 2014 | 265 | 2014 |
| Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study JL Pablos, M Galindo, L Carmona, A Lledó, M Retuerto, R Blanco, ... Annals of the rheumatic diseases 79 (12), 1544-1549, 2020 | 241 | 2020 |
| Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course L Cavagna, E Trallero-Araguás, F Meloni, I Cavazzana, J Rojas-Serrano, ... Journal of clinical medicine 8 (11), 2013, 2019 | 167 | 2019 |
| Adipokines: linking metabolic syndrome, the immune system, and arthritic diseases V Francisco, C Ruiz-Fernández, J Pino, A Mera, MA González-Gay, ... Biochemical pharmacology 165, 196-206, 2019 | 167 | 2019 |
| Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases JL Pablos, L Abasolo, JM Alvaro-Gracia, FJ Blanco, R Blanco, I Castrejón, ... Annals of the rheumatic diseases 79 (9), 1170-1173, 2020 | 165 | 2020 |
| Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta … A Souto, E Salgado, JR Maneiro, A Mera, L Carmona, JJ Gómez‐Reino Arthritis & Rheumatology 67 (1), 117-127, 2015 | 165 | 2015 |
| Tocilizumab in giant cell arteritis: multicenter open-label study of 22 patients J Loricera, R Blanco, JL Hernández, S Castañeda, A Mera, ... Seminars in arthritis and rheumatism 44 (6), 717-723, 2015 | 158 | 2015 |
| Adipokines and inflammation: is it a question of weight? V Francisco, J Pino, MA Gonzalez‐Gay, A Mera, F Lago, R Gómez, ... British journal of pharmacology 175 (10), 1569-1579, 2018 | 149 | 2018 |
| Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial X Baraliakos, L Gossec, E Pournara, S Jeka, A Mera-Varela, S d'Angelo, ... Annals of the rheumatic diseases 80 (5), 582-590, 2021 | 137 | 2021 |
| Biomechanics, obesity, and osteoarthritis. The role of adipokines: When the levee breaks V Francisco, T Pérez, J Pino, V López, E Franco, A Alonso, ... Journal of Orthopaedic Research® 36 (2), 594-604, 2018 | 134 | 2018 |
| Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis JR Maneiro, A Souto, E Salgado, A Mera, JJ Gomez-Reino RMD open 1 (1), e000017, 2015 | 108 | 2015 |
| Serum interleukin-12, interleukin-15, soluble CD26, and adenosine deaminase in patients with rheumatoid arthritis OJ Cordero, FJ Salgado, A Mera-Varela, M Nogueira Rheumatology international 21, 69-74, 2001 | 107 | 2001 |
| Molecular relationships among obesity, inflammation and intervertebral disc degeneration: are adipokines the common link? C Ruiz-Fernández, V Francisco, J Pino, A Mera, MA González-Gay, ... International journal of molecular sciences 20 (8), 2030, 2019 | 106 | 2019 |
| Effect of the first infliximab infusion on sleep and alertness in patients with active rheumatoid arthritis C Zamarron, F Maceiras, A Mera, JJ Gomez-Reino Annals of the rheumatic diseases 63 (1), 88-90, 2004 | 96 | 2004 |
| Progranulin as a biomarker and potential therapeutic agent V Abella, J Pino, M Scotece, J Conde, F Lago, MA Gonzalez-Gay, A Mera, ... Drug discovery today 22 (10), 1557-1564, 2017 | 89 | 2017 |
| A Comparison between Septic Bursitis caused by Staphylococcus aureus and those caused by other Organisms JC Cea-Pereiro, J Garcia-Meijide, A Mera-Varela, JJ Gomez-Reino Clinical Rheumatology 20, 10-14, 2001 | 89 | 2001 |
| Growth hormone treatment for sustained pain reduction and improvement in quality of life in severe fibromyalgia G Cuatrecasas, C Alegre, J Fernandez-Solà, MJ Gonzalez, ... Pain 153 (7), 1382-1389, 2012 | 83 | 2012 |
